2025 · 2nd Quarter (Apr 1 - June 30)

INCYTE CORPORATION

Filed by W STRATEGIES, LLC.

Open official filing

Source-reported fields

Filing overview

Type: 2nd Quarter - Report
Posted: Jul 18, 2025
Income: $60,000.00
Expenses: Not reported
Registrant: W STRATEGIES, LLC
Client: INCYTE CORPORATION
Filing UUID: e119bb7e-cd63-420a-83dc-80e2aed9cf56
Termination date: Not reported

Literal source text

Lobbying issues and bill citations

HCR · Health Issues

Education around access to innovative therapies in dermatology. Issues related to the 340(b)program.

MMM · Medicare/Medicaid

Issues related to Medicaid Drug Rebate program rule. H.R.1 - One Big Beautiful Bill Act, as it relates to H.R.946 - ORPHAN Cures Act.

Literal federal measure citations: H.R.1, H.R.946

Relationship and amount limits

Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.